(PKI)

業務介紹

柏金埃尔默公司在全球范围内为诊断、生命科学和应用服务市场提供产品、服务和解决方案。它通过两个业务部门运营,分别是发现与分析解决方案部门和诊断部门。

发现与分析解决方案部门提供一系列解决方案,包括试剂、信息学以及检测和成像技术,使科学家能够在生命科学研究市场上取得突破性进展,同时还提供合同研究和实验室服务。该部门还为环境、食品和工业市场提供分析技术、解决方案和服务,使客户能够了解和描述各种方面的健康状况,包括空气、水和土壤。此外,该部门还为农民和食品生产商提供解决方案,并为化工、半导体和电子、能源、润滑剂、石化和聚合物等工业市场提供分析仪器。

诊断部门提供用于早期检测遗传障碍(如怀孕和幼儿期)以及诊断市场感染性疾病检测的仪器、试剂、检测平台和软件产品。其产品用于检测和筛查各种遗传异常、障碍和疾病,包括唐氏综合症、甲状腺功能减退症、肌肉萎缩症、不孕症和各种代谢性疾病。该部门还开发能够支持基于蛋白偶联受体和下一代DNA测序的基因组工作流程的技术,应用于肿瘤学、免疫诊断和药物发现。

柏金埃尔默公司成立于1937年,总部位于马萨诸塞州沃尔瑟姆。



PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

公司網址

https://www.perkinelmer.com